Paz-Ares, L; Ciuleanu, TE; Cobo, M; Schenker, M; Zurawski, B; Menezes, J; Richardet, E; Bennouna, J; Felip, E; Juan-Vidal, O; Alexandru, A; Sakai, H; Lingua, A; Salman, P; Souquet, PJ; De Marchi, P; Martin, C; Perol, M; Scherpereel, A; Lu, S; John, T; Carbone, DP; Meadows-Shropshire, S; Agrawal, S; Oukessou, A; Yan, JC; Reck, M – 2021
First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in patients with non-small-cell lung cancer (CheckMate 9LA): an international, randomised, open-label, phase 3 trial
por prodriguez | Ene 1, 2021 | Publicaciones - CIMO-02 | 0 Comentarios